start
Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
start [2023/08/31 15:07] – chk | start [2024/07/16 15:13] (current) – chk | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== IRPCM ====== | ====== IRPCM ====== | ||
- | The __**I**__nternational __**R**__esearch __**P**__rogramme on __**C**__omparative __**M**__ycoplasmology (**IRPCM**) is a permanent standing committee of the [[https:// | + | The __**I**__nternational __**R**__esearch __**P**__rogramme on __**C**__omparative __**M**__ycoplasmology (**IRPCM**) is a permanent standing committee of the [[https:// |
- | In furtherance of the objective, the IRPCM is organized into individual teams with specific focus. Through team activities, we aim to promote effective exchange of scientific information and collaborations. The goals of these IRPCM teams include these aspects of Mycoplasmology: | + | In furtherance of the objective, the IRPCM is organized into individual teams with specific focus. Through team activities, we aim to promote |
* Elucidating the biological diversity, include the description of novel taxa and improvement of taxonomy | * Elucidating the biological diversity, include the description of novel taxa and improvement of taxonomy | ||
* Facilitating omics studies for global views of evolution, gene content and expression regulation, and the link to pathogenesis | * Facilitating omics studies for global views of evolution, gene content and expression regulation, and the link to pathogenesis | ||
Line 11: | Line 11: | ||
* Identifying more effective means of diagnosis, prevention, and control of mycoplasma-associated diseases | * Identifying more effective means of diagnosis, prevention, and control of mycoplasma-associated diseases | ||
- | + | Additionally, | |
- | Additionally, | + | |
* <color blue> | * <color blue> | ||
* <color blue> | * <color blue> | ||
start.1693494446.txt.gz · Last modified: 2023/08/31 15:07 by chk